Klotho: promising animal results, early human research

Preserving a sharp mind and an active body is central to aging well. Klotho has attracted attention because it appears to connect with both. This naturally occurring protein helps regulate important processes in the body, and experiments suggest that some forms of it may also influence how the brain and other tissues cope with aging. [1] [2] [6]

The excitement comes from a combination of findings: older monkeys performed better in a memory task after receiving Klotho, and a separate genetic approach extended survival in a small group of male mice. Human research is now exploring how to turn these ideas into a treatment. [1] [2] [3]

Our part in Klotho research

Healthy Longevity Clinic collaborates with Klothea Bio on Klotho research connected with XPRIZE. Klothea and HLC are also part of the Longevity Tech Fund portfolio. We are proud to help advance a field whose goal is meaningful: more years with useful memory, strength and independence. Klothea's program is investigating an mRNA approach to producing Klotho in the body. [13] [16]

What Klotho does

Klotho is not a single-purpose “longevity switch.” One form sits on cell membranes and helps a hormone called FGF23 regulate minerals and vitamin D. Part of the protein can also be released into body fluids. These different forms have prompted researchers to ask which functions might be useful for protecting health as we age. [6]

That distinction matters when developing a treatment. Researchers can give a manufactured protein directly, use mRNA as temporary instructions for making it, or deliver instructions through DNA. These approaches can produce different forms and amounts of Klotho for different lengths of time. The choice shapes both the hoped-for benefit and the questions about safety. [1] [2] [3] [4]

A memory boost in older monkeys

In a 2023 study, older rhesus monkeys learned to remember where food was hidden. After a single low dose of Klotho, they performed better, including on a more demanding version of the task. The improvement could still be detected more than two weeks later. [1]

One intriguing finding was that higher doses did not give the same clear benefit. This suggests that getting the amount right may matter as much as choosing the biological target. A later reanalysis broadly supported the main finding while correcting aspects of the statistical analysis. [1] [8]

This was a small experiment involving 18 monkeys across its cognitive tests. Remembering hidden food is a useful way to study memory, but it cannot capture all the abilities a person needs to manage daily life. The study gives researchers a strong reason to explore the idea further, including whether benefits can be sustained.

What the mouse study adds

A separate study used a viral carrier to deliver instructions for a short form of Klotho. In the male mice treated at 12 months, the age at which half the group had died rose from 24.6 months in the comparison group to 28.3 months—an increase of about 15%. Selected measures of physical and tissue health also improved. [2] [9]

That is a promising result, with a specific scope. Each male survival group contained only about a dozen animals, and the older treatment group lacked a control group injected at the same age. Health problems prevented a useful survival comparison in females. Larger studies will help show how reliably the benefit occurs and which animals are most likely to benefit.

The mouse treatment was also quite different from the protein given to monkeys. It involved genetic delivery through both the circulation and a brain ventricle. The result helps build the scientific case for Klotho, while leaving the design of an effective human treatment as a separate challenge. [2]

What we can learn from Klotho in human blood

Researchers have also studied people's naturally occurring Klotho levels. Several studies link higher levels with favorable findings in cognitive tests or brain measurements. The pattern varies with age, genetic background and the particular ability being tested. [10] [11] [12]

These observations are useful clues about biology. They do not yet tell us that raising someone's Klotho level will improve memory. A genetic analysis did not support a simple causal link between higher circulating Klotho and lower dementia risk. Taken together, the research points toward a more interesting question than “how high can we raise it?”: which form, amount and timing might actually help? [12]

The first steps in human treatment research

Klothea's AKL003 program uses mRNA carried in lipid particles to provide instructions for producing alpha-Klotho. Its early study is designed to compare treatment with a placebo in about 21 healthy volunteers. The main focus is safety and how well the treatment is tolerated, alongside blood measurements and exploratory tests of physical and cognitive function. The listed study site is GARM in Roatán, Honduras. [3] [13]

Minicircle is exploring another approach: a circular piece of DNA called a plasmid. Its early human studies include Klotho alone and a separate combination of Klotho with follistatin. These small studies follow safety and biological responses; their designs differ from the placebo-controlled Klothea study. [4] [5] [14]

The field is still at an early stage. These programs are working toward answers about human benefit; they have not established that Klotho treatment prevents dementia or extends human life. An entry in a trial registry describes research and does not by itself make a product an approved treatment. [15]

Why the form of the protein matters

Klotho's role in mineral regulation makes calcium, phosphate and bone health important parts of safety monitoring. In one mouse experiment, a longer form disturbed mineral levels and worsened bone measurements, while a shorter form did not produce those effects under the same study conditions. [7]

This is a practical lesson for drug development: a promising biological target still needs the right product. Researchers must understand how much protein is produced, where it acts, how long its effects last and whether unwanted changes develop over time.

From an intriguing protein to better daily life

For us, the most compelling outcome would be a person retaining an ability that matters: remembering appointments, staying physically capable or managing daily life independently. Blood measurements can help explain how a treatment works. The ultimate question is whether people benefit.

Healthy Longevity Clinic’s approach to evaluating evidence brings that practical perspective to emerging science. Through our collaboration with Klothea, we are helping explore one route toward that goal. Our research and scientific collaboration overview explains the wider work.

Klotho offers a compelling scientific lead, and human studies are the next essential chapter. If you are considering a research opportunity, understand the exact product, the aim of the study and the follow-up involved. Early participation is a contribution to learning as well as a personal decision about potential benefits and risks.